Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019

•Patients with elevated KL-6 had more reported symptoms and longer hospitalization.•KL-6 was associated most parameters that influence severity and prognosis of COVID-19.•Elevated KL-6 levels were an independent risk factor for prolonged hospitalization. The clinical relevance of Krebs von den Lunge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytokine (Philadelphia, Pa.) Pa.), 2021-12, Vol.148, p.155513-155513, Article 155513
Hauptverfasser: Chen, Hao, Qin, Rundong, Huang, Zhifeng, Luo, Wenting, Zheng, Peiyan, Huang, Huimin, Hu, Haisheng, Wang, Hui, Sun, Baoqing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Patients with elevated KL-6 had more reported symptoms and longer hospitalization.•KL-6 was associated most parameters that influence severity and prognosis of COVID-19.•Elevated KL-6 levels were an independent risk factor for prolonged hospitalization. The clinical relevance of Krebs von den Lungen-6 (KL-6) levels in patients with coronavirus disease 2019 (COVID-19) is unclear. This study aimed to evaluate the correlation between KL-6 levels, laboratory parameters, and clinical outcomes. We enrolled 364 patients with confirmed COVID-19 who were hospitalized within 1 week of symptom onset. Their serum KL-6 level was measured on admission. Demographic data, symptoms, comorbidities, and laboratory parameters were recorded at the time of admission. Days to nucleic acid conversion and days of hospitalization were defined as clinical outcomes for evaluating the clinical relevance of serum KL-6 levels in COVID-19. Patients with elevated KL-6 levels were significantly older; had more reported instances of fever, cough, fatigue, and wheezing; and a longer hospital stays than those with normal KL-6 levels; the difference was statistically significant (p 
ISSN:1043-4666
1096-0023
DOI:10.1016/j.cyto.2021.155513